NorthWest Biotherapeutics Inc (NWBO)

[barnstormer]

Concur that the time needed to complete the peer-review process is beyond their ability to control. Disagree that they lack any control over the TLD and journal article release. Assuming the review results and TLD are as good as anticipated, there will be more than one reputable journal anxious to publish, and the company can use that competition as a lever to arrive at a satisfactory result. In the end, just another contract that needs to be agreeable to both parties. If not, the company goes to a competitor.